ArticleBBA clinical2016

Treatment with recombinant human bone morphogenetic protein 7 leads to a transient induction of neutralizing autoantibodies in a subset of patients.

Andrea Schuette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.